Skip to main content
Download PDF
- Main
Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo.
- Author(s): Mobasher, P
- Guerra, R
- Li, SJ
- Frangos, J
- Ganesan, AK
- Huang, V
- et al.